19
May
2011
11
Jan
2011
01
Dec
2008
30
Nov
2008
Posted in I - Series C, Q - 2Q08, R - NORTH EAST, X - HIV, X - MRSA, X - Pain, X - Schizophrenia
Concert Pharmaceuticals (Lexington, MA) development-stage pharmaceutical company focused on new chemical entities based upon modifications of validated drug molecules using deuterium chemistry, closed a $37M Series C financing. Participants include Adage Capital Management, SR One, Mediphase Venture Partners, Westfield Capital Management, Three Arch Partners, TVM Capital, Skyline Ventures, Brookside Capital Partners Fund, Flagship Ventures, [...]
05
Feb
2008